| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Xbrane Biopharma AB (publ) (ST: XBRANE)
XBRANE Technical Analysis
5
| As on 28th Mar 2025 XBRANE STOCK Price closed @ 0.21 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 4.56 & Strong Sell for SHORT-TERM with Stoploss of 15.62 we also expect STOCK to react on Following IMPORTANT LEVELS. |
XBRANESTOCK Price
| Open | 0.23 | Change | Price | % |
| High | 0.24 | 1 Day | -0.02 | -8.70 |
| Low | 0.21 | 1 Week | 0.06 | 40.00 |
| Close | 0.21 | 1 Month | 0.05 | 31.25 |
| Volume | 12580758 | 1 Year | -18.35 | -98.87 |
| 52 Week High 25.95 | 52 Week Low 0.13 | ||||
ST Sweden Most Active Stocks
| ATORX | 0.01 | 0.00% |
| FING-B | 0.01 | 0.00% |
| HDW-B | 0.00 | % |
| QUIA | 0.01 | % |
| DSNO | 0.13 | 8.33% |
| ENERS | 0.00 | % |
| QLINEA | 0.04 | 0.00% |
| LUNE | 21.97 | 6.65% |
| SBB-B | 3.48 | 2.05% |
| XBRANE | 0.21 | -8.70% |
ST Sweden Top Gainers Stocks
ST Sweden Top Losers Stocks
| XBRANE Daily Charts |
XBRANE Intraday Charts |
Whats New @ Bazaartrend |
XBRANE Free Analysis |
|
|
XBRANE Important Levels Intraday
| RESISTANCE | 0.27 |
| RESISTANCE | 0.25 |
| RESISTANCE | 0.24 |
| RESISTANCE | 0.23 |
| SUPPORT | 0.19 |
| SUPPORT | 0.18 |
| SUPPORT | 0.17 |
| SUPPORT | 0.15 |
XBRANE Forecast March 2025
| 4th UP Forecast | 23.33 |
| 3rd UP Forecast | 15.92 |
| 2nd UP Forecast | 11.33 |
| 1st UP Forecast | 6.75 |
| 1st DOWN Forecast | -6.33 |
| 2nd DOWN Forecast | -10.91 |
| 3rd DOWN Forecast | -15.5 |
| 4th DOWN Forecast | -22.91 |
XBRANE Weekly Forecast
| 4th UP Forecast | 4.14 |
| 3rd UP Forecast | 2.88 |
| 2nd UP Forecast | 2.10 |
| 1st UP Forecast | 1.32 |
| 1st DOWN Forecast | -0.90 |
| 2nd DOWN Forecast | -1.68 |
| 3rd DOWN Forecast | -2.46 |
| 4th DOWN Forecast | -3.72 |
XBRANE Forecast2025
| 4th UP Forecast | 51.51 |
| 3rd UP Forecast | 35.06 |
| 2nd UP Forecast | 24.89 |
| 1st UP Forecast | 14.72 |
| 1st DOWN Forecast | -14.3 |
| 2nd DOWN Forecast | -24.47 |
| 3rd DOWN Forecast | -34.64 |
| 4th DOWN Forecast | -51.09 |
Xbrane Biopharma AB (publ) ( ST Sweden Symbol : XBRANE )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
XBRANE Business Profile
Xbrane Biopharma AB (publ), a biotechnology company, develops, manufactures, and sells biosimilars. The company is developing Xlucane, a ranibizumab biosimilar that is in Phase III clinical trials used for the treatment of wet age-related macular degeneration, diabetic macular edema, diabetic related retinopathy, and retinal vein occlusion. Its pre-clinical phase products include Xcimzane for rheumatoid arthritis, axial spondylarthrosis, psoriatic arthritis, and psoriasis and crohn diseases; Xoncane for acute lymphocytic leukemia; Spherotide for prostate cancer, breast cancer, endometriosis, and myoma; and Xdivane for melanoma, lung, head and throat, bladder, and urinary tract cancer, as well as for renal cell carcinoma. The company has a strategic biosimilar development partnership with STADA Arzneimittel AG to evaluate development and commercialization collaborations around its Xcimzane and Xdivane preclinical biosimilars. Xbrane Biopharma AB (publ) was founded in 2008 and is headquartered in Solna, Sweden. Address: Retzius väg 8, Solna, Sweden, 171 65
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service